A Phase I Study to Determine the Safety of Multiple Oral Doses of Niclosamide in Healthy Volunteers
Phase 1
- Conditions
- Therapeutic for Zika virus treatment
- Registration Number
- ACTRN12618001441202
- Lead Sponsor
- Ala Wai Pharma Pty Ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- All
- Target Recruitment
- 12
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method